Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven K Libutti

Showing results (11-20 of 222) with videos related to

Pageof 23
Sort By:
Expert Opinion on Therapeutic Targets|September 10, 2014
Filamin A interacting protein 1-like as a therapeutic target in cancerMijung Kwon, Steven K Libutti
Advances in Genetics|September 3, 2010
Strategies for targeting tumors and tumor vasculature for cancer therapyPrashanth Sreeramoju, Steven K Libutti
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
Advances in understanding angiogenesis through molecular studiesMijung Kwon, Steven K Libutti
Seminars in Oncology|December 21, 2010
Future diagnostic and therapeutic trends in endocrine cancersAllen M Spiegel, Steven K Libutti
Surgical Oncology Clinics of North America|March 11, 2020
Management of Other Gastric and Duodenal Neuroendocrine TumorsAmanda M Laird, Steven K Libutti
Surgical Oncology Clinics of North America|August 3, 2006
Gastrinoma: sporadic and familial diseaseSteven K Libutti, H Richard Alexander
Surgical Oncology Clinics of North America|November 28, 2015
Minimally Invasive Parathyroidectomy Versus Bilateral Neck Exploration for Primary HyperparathyroidismAmanda M Laird, Steven K Libutti
Expert Opinion on Biological Therapy|June 25, 2002
Microarray technology and gene expression analysis for the study of angiogenesisNick G Costouros, Steven K Libutti
Journal of Biology|October 30, 2009
Targeting TNF-alpha for cancer therapyElizabeth R Burton, Steven K Libutti
Cancer Treatment and Research|December 4, 2009
Multiple endocrine neoplasia type 1: clinical manifestations and managementAnathea C Powell, Steven K Libutti
Pageof 23

Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Expert Opinion on Therapeutic Targets|September 10, 2014
Filamin A interacting protein 1-like as a therapeutic target in cancerMijung Kwon, Steven K Libutti
Advances in Genetics|September 3, 2010
Strategies for targeting tumors and tumor vasculature for cancer therapyPrashanth Sreeramoju, Steven K Libutti
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
Advances in understanding angiogenesis through molecular studiesMijung Kwon, Steven K Libutti
Seminars in Oncology|December 21, 2010
Future diagnostic and therapeutic trends in endocrine cancersAllen M Spiegel, Steven K Libutti
Surgical Oncology Clinics of North America|March 11, 2020
Management of Other Gastric and Duodenal Neuroendocrine TumorsAmanda M Laird, Steven K Libutti
Surgical Oncology Clinics of North America|August 3, 2006
Gastrinoma: sporadic and familial diseaseSteven K Libutti, H Richard Alexander
Surgical Oncology Clinics of North America|November 28, 2015
Minimally Invasive Parathyroidectomy Versus Bilateral Neck Exploration for Primary HyperparathyroidismAmanda M Laird, Steven K Libutti
Expert Opinion on Biological Therapy|June 25, 2002
Microarray technology and gene expression analysis for the study of angiogenesisNick G Costouros, Steven K Libutti
Journal of Biology|October 30, 2009
Targeting TNF-alpha for cancer therapyElizabeth R Burton, Steven K Libutti
Cancer Treatment and Research|December 4, 2009
Multiple endocrine neoplasia type 1: clinical manifestations and managementAnathea C Powell, Steven K Libutti
Pageof 23